ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SN. Smith & Nephew Plc

1,125.50
0.00 (0.00%)
27 Feb 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Smith & Nephew Plc SN. London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1,125.50 00:00:00
Open Price Low Price High Price Close Price Previous Close
1,125.50
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Smith & Nephew SN. Dividends History

Announcement Date Type Currency Dividend Amount Ex Date Record Date Payment Date
03/08/2023InterimUSD0.14405/10/202306/10/202301/11/2023
21/02/2023FinalUSD0.23130/03/202331/03/202317/05/2023
28/07/2022InterimUSD0.14429/09/202230/09/202226/10/2022
22/02/2022FinalUSD0.23131/03/202201/04/202211/05/2022

Top Dividend Posts

Top Posts
Posted at 13/10/2023 11:43 by essentialinvestor
Might be worth looking at what the CEO does.. ?

His large sales at £12.74 and £12.78 now look very astute.


5 different CEO's in 10 years, eh


A rating of 16 X forward looks more than fair for SN. in a post ZIRP world.
The market might see it differently, but that's how it looks to me.
Posted at 12/10/2023 13:58 by essentialinvestor
Laurence, part of the issue is arguably their main competitors growing stronger
v SN over the last decade. This may account for some of SN's weaker metrics.

While a bid can't be ruled out, it has been mentioned as a takeover candidate for decades.

If you go back 10 years, this was a high margin business with low gearing and
a prodigious cash generator. Those bullish on SN may say that's now reflected in
the current share price, however circa 2013, at approx £8 plus a share you were
buying at the time a great business.
Posted at 12/10/2023 08:01 by essentialinvestor
How are margins stable?, trading profit margin registered a hefty fall at the H1 to
15.3%.

For years SN had trading profit margins in excess of 20%, for a few years around 24/25%.

Margins began a multi year decline around 2015/16 (from memory)
and despite multiple CEO's since, each with a new refreshed strategy
to improve business performance, results have arguably been sadly lacking.


Margin compression leading to reduced free cash flow is central to the bearish case on SN.
Posted at 11/10/2023 14:15 by essentialinvestor
Stryker do not need SN, while you can't rule a bid out I would be surprised to see one from Stryker.
Posted at 05/10/2023 07:27 by pugugly
Ex Dividend today - 11.915p
Posted at 21/2/2023 08:42 by adamb1978
Nothing exciting no, but equally still nothing to suggest that they're ever going to deliver decent ROE, ROCE etc

Always felt to me that SN achieves a fraction of its potential. Why...I'm not sure
Posted at 07/12/2022 15:38 by suetballs
Glad this wasn't sn.
Suet
Posted at 04/11/2022 17:32 by cerrito
As a SN. holder I listened to most of the recording of yesterday's webcast.
Alot of good stuff especially in logistics and optimization of inventory and US improvement but what stopped me pushing the buy button was not so much the supply shortages(especially semi conductors and resins) but rather that in the Q&A the difficulty they were having on passing on cost increases came up 2/3 times.
Posted at 03/11/2022 10:19 by disc0dave45
Seem to be following the same stocks!From the healthcare sector I've got SN on my watchlist and good to see they are in line. Some of the constraining factors (materials and staff shortages, FX headwinds) could develop into major issues but who knows.
Posted at 28/7/2022 12:44 by essentialinvestor
£13/4 bn to take this out - plus their £2 bn approx in net debt.


Is SN. worth £15 bn...looks a stretch to me but never say never.


Stryker already carry a lump of debt, realistically only leaves JnJ imv.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com